Liver fibrosis is a typical outcome of constant liver sickness. After some time, liver fibrosis can form into liver cirrhosis. Momentum treatments for liver fibrosis are constrained, and liver transplant is the main remedial treatment for patients who progress to end-stage sickness. A potential way to deal with treat interminable liver sickness with expanding interest is cell-based treatment. Among the numerous cell types which have been proposed for helpful utilizations, human amnion epithelial cells and amniotic liquid determined mesenchymal cells are promising. These cells are profoundly rich, and their utilization represents no moral concern. Besides, they apply strong calming and antifibrotic impacts in creature models of liver injury. This survey features the remedial attributes and examines how human amnion epithelial cells can be used as a restorative device for incessant liver ailment.